Citation record · us-2024-fda-approves-treatment

US Food and Drug Administration, FDA approves treatment for adults with Alzheimer’s disease, news release on donanemab, July 2024

resource 2024 not re-checked

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-adults-alzheimers-disease

Authors. US Food and Drug Administration

Venue. news release on donanemab, July 2024

How the Institute flags it

established 1 time

Cited on 1 page

Neurodegeneration Reversal

The evidence base

Search · Citation record

Every source the Institute cites, searchable by title, kind and verification state.